bluuebunny/crossref_metadata_2025_split huggingface dataset:
The role of public school principals and teachers in developing the social responsibility of students with learning disabilities: a joint perspective
Authors: Alsarayreh Khaled Shaker Turki , Alramamneh Abdellatif Khalaf , Al-Sabayleh Obaid Abdelkarim , Al Remawi Sameer Abdel Kareem Ahmad 
Published: October 2024

IntroductionPublic school principals and teachers are crucial in shaping students with learning disabilities to become socially responsible individuals. Beyond academics, educators use adaptive teaching and leadership to instill values of empathy, cooperation, and civic duty in these students, ensuring they can contribute positively to their communities.AimThe present study aimed to identify the role of government school principals and teachers in developing the social responsibility of students with learning disabilities in the Kasbah of Salt from their viewpoint.MethodA descriptive analytical approach was used, where a random sample was taken from the principals and teachers of some of the Kasbah Al-Salt schools for the primary stage, and thus the sampling unit consisted of (106) principals and teachers, and the scale was sed, and it includes (27) items distributed on three dimensions of social responsibility (education, preservation Environment, community service).ResultsAccording to the findings of the study, the degree of social responsibility among students who have learning difficulties is comparable to the average level. However, the study also discovered that there are disparities in the level of social responsibility due to the gender variable, and these differences are in favor of males. In addition, there were no differences that could be considered statistically significant between the levels of social responsibility and the educational level variable.Scientific noveltyThe study’s novelty lies in its exploration of educators’ views on fostering social responsibility in students with learning disabilities in the specific context of the Kasbah of Salt. The research uses a descriptive analytical method, focuses on primary schools in Kasbah Al-Salt, employs the structured Melhem (2018) scale for evaluation, and reveals gender as a significant factor in social responsibility, while educational level is not.
Prehospital point of care ultrasound in Helicopter Emergency Medical Services: a 5-year experience study in Belgium
Authors: Betz Romain , Gilbert Allison , Moens Didier , Marissiaux Laurent , Paquay Meryl , Lopez Iglesias Raphaëlle , Pirotte Olivier , Ghuysen Alexandre , Stipulante Samuel 
Published: October 2024

IntroductionThe utilization of Clinical Ultrasound (CUS) in Helicopter Emergency Medical Services (HEMS) has become increasingly prevalent, reflecting its significant role in emergency care.MethodsThis descriptive, monocentric study, conducted at the Helicopter Medical Center (CMH) of Bra-sur-Lienne, Belgium, aimed to describe the use of CUS within HEMS and evaluate its potential impact on diagnostic accuracy, therapeutic interventions, and hospital destination decisions.ResultsOver a 5-year period, from January 2018 to December 2022, our retrospective analysis included 6,126 HEMS interventions, with CUS performed in 29.55% of cases. The study demonstrated that CUS led to therapeutic changes in 30.88% of instances and affected the hospital destination in 9% of cases, despite a potential bias toward directing patients to the University Hospital Center of Liège (CHU of Liège) due to operational constraints. The agreement between prehospital CUS findings and hospital imaging was substantial, with an 80.39% concordance rate, underscoring CUS's utility in enhancing prehospital diagnostic accuracy. We found no significant increase in on-scene time due to CUS usage, with most exams completed in &lt;5 min.DiscussionOur findings highlight the interesting role of CUS in HEMS, facilitating more informed and confident medical decision-making in prehospital emergency care. However, variability in CUS application emphasize the need for standardized guidelines to optimize its use. The study's limitations include its retrospective, monocentric design and the focus on on-scene ultrasound evaluations. Future research should aim at a more extensive, prospective analysis to further validate the benefits of CUS in emergency medical services.
Self-puberty staging in endocrine encounters during the COVID pandemic
Authors: Ebo Chineze , McCray Jordyn , Bowers Katherine , Rose Susan R. , Jones Nana-Hawa Yayah 
Published: October 2024

BackgroundEvaluation of pubertal development is crucial in Endocrinology. The rise in telemedicine during COVID-19 has made conduct of physical examinations more challenging, especially for pubertal assessment. Previous studies on validity of pubertal self-staging versus clinical examination have yielded mixed results. This study aimed to determine validity and reliability of self-staging of puberty, with potential application during telemedicine visits. The present study is the first to assess pediatric self-rated pubertal staging during the pandemic.MethodsThe study included patients aged 7-22 years referred to Pediatric Endocrinology for specialty care, including pubertal staging. At clinic check-in, patients received a packet with study description, an option to “opt in” or “opt out”, sex-specific self-staging instructions, and Tanner (T) stage illustrations. Males received materials for pubic hair (PH) stages T1-T5; females received materials for PH and breast (BR) stages T1-T5. Patients who opted in had 10 minutes to select the image(s) that best matched their bodies, which they sealed in an envelope. This was followed by a clinic visit, where a board-certified pediatric endocrinologist conducted a physical examination, including breast staging (females), testicular size measurement (males), and pubic hair staging (both sexes). Pubertal stage Kappa statistics with 95% CI were calculated for each body part by sex, with Kappa ≥ 0.60 indicating significant agreement between self-assessment and physician assessment (0.40-0.60 moderate; 0.20-0.40 fair).ResultsOf 516 distributed packets, 243 self-assessments (125 females) were returned, with 81% (94 females/102 males) being complete (including pediatric endocrinologist staging). Mean age of participants was 12.8 years. Mean BMI was 22.2 kg/m² (males) and 23.7 kg/m² (females). Hypothyroidism was the most common endocrine diagnosis. For females, kappa was highest for BR and PH in T1 (BR 0.65, PH 0.57) and T5 (BR 0.57, PH 0.65). For males, kappa was highest in T1 (0.73) and T2 (0.58). Grouping Tanner stages into prepuberty (T1), early to mid-puberty (T2-T3), and late puberty (T4-T5) showed greater agreement.ConclusionPatients can reliably distinguish between “puberty” and “no puberty” using self-staging, though differentiating between later pubertal stages is more challenging. These findings help define the utility and limitations of self-staging during telemedicine visits.
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
Authors: Najafi-Fard Saeid , Farroni Chiara , Petrone Linda , Altera Anna Maria Gerarda , Salmi Andrea , Vanini Valentina , Cuzzi Gilda , Alonzi Tonino , Nicastri Emanuele , Gualano Gina , Palmieri Fabrizio , Piacentini Mauro , Goletti Delia 
Published: October 2024

ObjectiveCysteamine, a drug approved to treat cystinosis, has been proposed as a host-directed therapy for M. tuberculosis (Mtb) and SARS-CoV-2. The impact of cysteamine on the immune responses has not been fully investigated. We aimed to in vitro evaluate the immunomodulatory effects of cysteamine on peripheral blood mononuclear cells (PBMCs) using the purified protein derivative (PPD) as a recall antigen, and an unspecific stimulus as staphylococcal enterotoxin B (SEB).MethodsPBMCs isolated from subjects with tuberculosis infection (TBI), those with tuberculosis disease (TB), and healthy controls (HC) were in vitro stimulated with PPD or SEB and treated or not with cysteamine at different concentrations (50 µM–400 µM) for 6 hours (h) and 24 h. We evaluated the T helper1 (Th1) and T cytotoxic1 (Tc1) cell cytokine production by flow cytometry and immune-enzymatic assays. In HC, we also evaluated apoptosis and/or necrosis by flow cytometry.ResultsWe observed an immunomodulatory effect of cysteamine at 400 µM in PBMCs from TB and TBI subjects. It significantly reduced PPD-specific Th1 responses at 24 h and at 6 h (p=0.0004 and p=0.0009, respectively), and a similar non-significant trend was observed with cysteamine at 200 µM (p=0.06 at 24 h and p=0.14 at 6 h). Moreover, cysteamine at both 400 µM (p&lt;0.0001 and p=0.0187 at 24 h, respectively, and p&lt;0.0001 at 6 h for both) and 200 µM (p=0.0119 and p=0.0028 at 24 h and p=0.0028 and p=0.0003 at 6 h, respectively) significantly reduced SEB-induced Th1 and Tc1 responses. Furthermore, we found that cysteamine induced morphological lymphocyte changes and significantly reduced the lymphocyte percentage in a dose- and time-dependent manner. Cysteamine at 400 µM induced 8% late apoptosis and 1.6% necrosis (p&lt;0.05) at 24 h. In contrast, despite significant differences from untreated conditions (p&lt;0.05), cysteamine at 400 µM for 6 h induced approximately 1% late apoptosis and 0.1% necrosis in the cells.ConclusionsHigh doses of cysteamine in vitro reduce the percentages of PPD- and SEB-induced Th1 and Tc1 cells and induce late apoptosis and necrosis. Differently, cysteamine at lower doses retains the immunomodulatory effect without affecting cell viability. These findings suggest cysteamine as a potential adjunct to antimicrobial regimens as in the TB or COVID-19 field, for its ability to reduce the inflammatory status.
Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus
Authors: Tong Wangxia , Zhong Jieyue , Yang Qiuyan , Lin Han , Chen Bolun , Lu Tao , Chen Jibing , Luo Ning 
Published: October 2024

BackgroundHepatocellular carcinoma (HCC) patients exhibiting portal vein tumor thrombosis (PVTT) face a high risk of rapid malignant progression and poor outcomes, with this issue being compounded by a lack of effective treatment options. The integration of bulk RNA-sequencing (RNA-seq) and single-cell RNA-seq (scRNA-seq) datasets focused on samples from HCC patients with PVTT has the potential to yield unprecedented insight into the dynamic changes in the tumor microenvironment (TME) and associated immunological characteristics in these patients, providing an invaluable tool for the reliable prediction of disease progression and treatment responses.MethodsscRNA-seq data from both primary tumor (PT) and PVTT cells were downloaded from the Gene Expression Omnibus (GEO) database, while the International Cancer Genome Consortium (ICGC) and Cancer Genome Atlas (TCGA) databases were used to access bulk RNA-seq datasets. scRNA-seq, clustering, GSVA enrichment, mutational profiling, and predictive immunotherapeutic treatment analyses were conducted using these data with the goal of systematically assessing the heterogeneity of PT and PVTT cells and establishing a model capable of predicting immunotherapeutic and prognostic outcomes in patients with HCC.ResultsThese analyses revealed that PVTT cells exhibited patterns of tumor proliferation, stromal activation, and low levels of immune cell infiltration, presenting with immune desert and immune rejection-like phenotypes. PT cells, in contrast, were found to exhibit a pattern of immunoinflammatory activity. Core PVTT-associated genes were clustered into three patterns consistent with the tumor immune rejection and immune desert phenotypes. An established clustering model was capable of predicting tumor inflammatory stage, subtype, TME stromal activity, and patient outcomes. PVTT signature genes were further used to establish a risk model, with the risk scores derived from this model providing a tool to evaluate patient clinicopathological features including clinical stage, tumor differentiation, histological subtype, microsatellite instability status, and tumor mutational burden. These risk scores were also able to serve as an independent predictor of patient survival outcomes, responses to adjuvant chemotherapy, and responses to immunotherapy. In vitro experiments were used to partially validate the biological prediction results.ConclusionThese results offer new insight into the biological and immunological landscape of PVTT in HCC patients, By utilizing individual patient risk scores, providing an opportunity to guide more effective immunotherapeutic interventional efforts.
Case report: Significant response of alpha-fetoprotein-producing gastric cancer from combined chemotherapy and immunotherapy
Authors: Da Xue , Juan Zhang , Zhijun Hu , Zhongchuan Lyu 
Published: October 2024

BackgroundAlpha-fetoprotein-producing gastric cancer (AFPGC) represents a particularly aggressive subtype of gastric carcinoma characterized by elevated rates of vascular invasion, lymphatic dissemination, hepatic metastasis, and an unfavorable clinical outcome. Treatment strategies for AFPGC have historically lacked specificity. Herein, a case is presented involving AFPGC in which the patient exhibited a notable response to combined anti-PD-1 antibody immunotherapy and SOX chemotherapy, potentially achieving a cure. This report marks the first application of this regimen in neoadjuvant therapy for AFP gastric cancer, followed by radical resection and postoperative adjuvant therapy.Case summaryA 62-year-old male patient presented with persistent upper abdominal distension and discomfort lasting over 2 months. Initial investigations revealed markedly elevated serum alpha-fetoprotein (AFP) levels, and subsequent pathological examination confirmed the diagnosis of AFPGC via gastroscopy. Due to the patient’s condition, surgical resection was initially deemed unfeasible. Therefore, a chemo-immunotherapy regimen consisting of SOX chemotherapy and the PD-1 inhibitor tislelizumab was administered for 3 cycles. Following this, successful laparoscopic radical gastrectomy was performed. The treatment protocol was continued with an additional 3 cycles postoperatively. At the time of this case report, the patient maintained a good quality of life with no evidence of disease recurrence or adverse events.ConclusionThe present report highlights a case of AFPGC where significant therapeutic success was achieved through a combined regimen of chemotherapy and immunotherapy, both before and after surgery. The use of anti-PD-1 antibody (tislelizumab) in combination with SOX regimen (S-1 and oxaliplatin) demonstrated effective treatment of AFPGC, potentially offering a curative approach. This approach represents a promising targeted therapy option for patients with AFPGC.
Electrophoretic deposition of polyetheretherketone/polytetrafluoroethylene on 316L SS with improved tribological and corrosion properties for biomedical applications
Authors: Imran Ayman , Malik Rizwan Ahmed , Alrobei Hussein , Ur Rehman Muhammad Atiq 
Published: October 2024

Introduction316L stainless steel (316L SS) has poor wear and corrosion resistance compared to that of the Cp-Ti and Ti-6Al-4V implants [when studied under a physiological environment using phosphate-buffered saline (PBS)]. However, 316L SS implants are cost-effective. Their wear and corrosion properties can be improved by depositing biocompatible coatings.MethodIn this research work, a polymer coating of polyetheretherketone (PEEK) and polytetrafluoroethylene (PTFE) was deposited at optimized parameters (20 V for 3 min) on 316L SS via electrophoretic deposition (EPD). We compared the performance between of the PEEK coating and hybrid PEEK/PTFE coatings for biomedical applications. The PEEK/PTFE coating was sintered at 350°C for 30 min.Results and DiscussionScanning electron microscopy (SEM) analysis revealed that the PEEK/PTFE coating showed a uniform coating with a uniform thickness of ∼80 µm. Fourier transform infrared (FTIR) spectroscopy analysis confirmed the presence of bonds attributed to the PEEK and PTFE coatings. The PEEK/PTFE coating exhibited adequate average surface roughness (Ra) of 2.1 ± 0.2 µm with a high value of contact angle of 132.71 ± 3, indicating the hydrophobic nature of the PEEK/PTFE coating. Scratch tests evaluated that the PEEK/PTFE coating demonstrated a 7 N load, which indicated the good adhesion between the coating and 316L SS. Furthermore, the PEEK/PTFE coating demonstrated good wear resistance, capable of withstanding a 7 N load under dry conditions, and showed a specific wear rate of ∼0.0114 mm3/Nm. Electrochemical analysis conducted using the phosphate-buffered saline (PBS) solution demonstrated that the corrosion rate of 316L SS was reduced from 0.9431 mpy to 0.0147 mpy by depositing the PEEK/PTFE coating. Thus, the developed coatings present suitable wear and corrosion resistance and are thus considered for potential orthopedic applications.
A sex-based analysis of complete blood count features during acute, untreated Lyme disease
Authors: Rebman Alison W. , Yang Ting , Zenilman Jonathan M. , Soloski Mark J. , Aucott John N. 
Published: October 2024

IntroductionAlthough lymphopenia has been described in acute Lyme disease (LD), the complete blood count (CBC) has not been comprehensively examined, nor have sex-based analyses been conducted. We analyzed CBC values and identified sex-based trends among patients with early LD by comparing both to controls without a history of LD and to patients’ pre-morbid values.MethodsWe enrolled participants from the Mid-Atlantic US with diagnostic erythema migrans and controls with no history of LD. CBC results were obtained, and patient information was recorded using standardized instruments. We also calculated a neutrophil-to-lymphocyte ratio (NLR). We used linear regression to test that CBC results would differ (a) between antibiotic-naive patients with early LD and controls and (b) by measures of acute disease severity. We also performed stratified analyses to assess sex-based differences.ResultsIn total, 236 antibiotic-naive patients with early LD had significantly lower lymphocytes (β = −0.34, p &lt; 0.001) and significantly higher monocytes (β = 0.09, p = 0.002) and NLRs (β = 0.99, p &lt; 0.001) than 61 controls in adjusted analyses. Lymphocytes, monocytes, and NLRs also changed significantly from pre-morbid to acute LD (p &lt; 0.001 for all). Only the NLR was consistently significantly associated with disease severity. A higher proportion of male patients with early LD had acute lymphopenia than female patients with early LD (31.93% vs. 19.66%, p = 0.03); this difference was not present among controls.ConclusionThe presence of lymphopenia and the absence of an elevated total white blood cell count make LD an important diagnostic consideration in patients presenting with undiagnosed infectious syndromes in endemic regions. This may be especially true for male patients.
Clinical characteristics and treatment efficacy in patients with primary severe IGF-1 deficiency treated with recombinant IGF-1
Authors: Denaite Dovile , Navardauskaite Ruta 
Published: October 2024

Aim of the studyTo evaluate the clinical characteristics and treatment efficacy of patients with severe primary IGF-1 deficiency (PSIGFD) using a recombinant IGF-1 (rhIGF-1).Objectives of the studyTo examine the clinical characteristics of patients with PSIGFD before starting treatment with a rIGF-1. To assess the height changes in patients with PSIGFD, before and after treatment with a rhIGF-1. To analyze the clinical characteristics, side effect frequency, and treatment efficacy with a rhIGF-1 analog in patients with PSIGFD.MethodsA retrospective analysis was conducted on patients with PSIGFD treated with the rhIGF-1 (mecasermin). Data were collected from patients’ medical records, focusing on the impact of treatment on their growth and monitoring any side effects.ResultsThe study showed that treatment with rhIGF-1 positively affects growth rate, especially in the first years of treatment. However, the growth rate decreases over time. The change in height from the beginning to the end of the treatment was 0.76 ± 0.64 SD, with the first quartile at 0.29 SD and the third quartile at 1.14 SD. During the treatment period, patients’ average body mass increased by 0.37 ± 1.35 SD, with the first quartile at −0.33 SD and the third quartile at 0.92 SD. Side effects occurred in 50% of patients, with 40% of patients treated with rhIGF-1 experiencing hypoglycemia during treatment.ConclusionsTreatment with rhIGF-1 is effective in treating patients with PSIGFD, causing significant improvement in growth, but requires continuous monitoring and treatment adjustment.
Effectiveness of psychological interventions in endometriosis: a systematic review with meta-analysis
Authors: del Pino-Sedeño Tasmania , Cabrera-Maroto María , Abrante-Luis Alejandra , González-Hernández Yadira , Ortíz Herrera M Caridad 
Published: October 2024

IntroductionEndometriosis is a chronic gynecological disease associated with chronic debilitating pain, poor mental health and quality of life. The objective of this paper is to evaluate the effectiveness of psychological interventions aimed at improving the pain, quality of life and mental health of women with endometriosis.MethodsA systematic review (SR) of the literature with meta-analysis (MA) was carried out. MEDLINE, Embase, PsycINFO and CENTRAL were searched to locate Randomized Controlled Trials (RCTs). The risk of bias assessment of each study was conducted using the Cochrane Collaboration’s RoB 2.0 tool.ResultsSeven RCTs were included (N = 757). The data obtained suggest that psychological interventions reduce dyspareunia [standardized mean difference (SMD): -0.54, 95% CI: −0.86, −0.22] and dyschezia [mean difference (MD): -2.90, 95% CI: −4.55, −1.26] and increase mental health levels (SMD: 0.70, 95% CI: 0. 42, 0.99); they also point to a large reduction in levels of trait anxiety (MD: -6.63, 95% CI: −8.27, −4.99) and depression (MD: -2.49, 95% CI: −3.20, −1.79), and a likely reduction in state anxiety (MD: -9.72, 95% CI: −13.11, −6.33) experienced by women with endometriosis. It was also identified that psychological interventions probably slightly reduce pelvic pain and may increase physical health. However, most of the included studies have a high overall risk of bias or have certain concerns, which limit conclusions about the certainty of the evidence.DiscussionThe available evidence indicates that psychological interventions are effective in improving the pain, quality of life and mental health variables of women with endometriosis.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, CRD42024516100.